Dr. Drapkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
Weill Cornell MedicineClass of 2010
Certifications & Licensure
TX State Medical License 2020 - 2025
MA State Medical License 2018 - 2021- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brie...Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, Kenneth D Westover, Sawsan Rashdan
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01 - Jumonji histone demethylases are therapeutic targets in small cell lung cancer.Aiden Nguyen, Clarissa G Nuñez, Tram Anh Tran, Luc Girard, Michael Peyton
Oncogene. 2024-09-01 - 3 citationsMammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer.Leslie Duplaquet, Kevin So, Alexander W Ying, Shreoshi Pal Choudhuri, Xinyue Li
Cancer Cell. 2024-08-12
Press Mentions
Lung Cancer Treatment Shows Promise in Tumor ModelsMarch 12th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
